acetaminophen has been researched along with bromopyruvate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, AA; Ahmed, AS; Ahmed, NS; Amer, WH; El Sayed, SM; Hamed, AR; Helmy Nabo, MM; Mahmoud, AG; Mohamed, WG; Seddik, MA | 1 |
| Almaramhy, HH; Ayat, M; Baghdadi, H; Donki, JG; El Sayed, SM; Zolaly, M | 1 |
1 review(s) available for acetaminophen and bromopyruvate
| Article | Year |
|---|---|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
Topics: Acetaminophen; Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glycolysis; Hexokinase; Humans; L-Lactate Dehydrogenase; Lactic Acid; Lung Neoplasms; Male; Melanoma; Necrosis; Neovascularization, Pathologic; Pleural Neoplasms; Prognosis; Pyruvates; Treatment Outcome | 2014 |
1 other study(ies) available for acetaminophen and bromopyruvate
| Article | Year |
|---|---|
The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view.
Topics: Acetaminophen; Administration, Oral; Albumins; Alkylating Agents; Animals; Antineoplastic Agents; Cisplatin; Drug Resistance, Neoplasm; Evidence-Based Medicine; Glutathione; Humans; Infusions, Intravenous; Melanoma; Models, Theoretical; Pyruvates; Serine | 2017 |